Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Marta Iraola Iribarren

Pfizer and Valneva's Lyme disease vaccine shows 70% efficacy in clinical trial

A Lyme disease vaccine has shown efficacy in a clinical trial and paves the way for marketing authorisation, pharmaceutical companies Pfizer and the French Valneva announced on Monday.

Lyme disease is a bacterial illness transmitted to humans through the bite of infected ticks.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.